🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/05/2012 | 36,55 | 36,85 | 36,50 | 36,63 | +0,79% | 0,97% | 9.906.430 |
| 09/05/2012 | 36,58 | 36,73 | 36,35 | 36,35 | -1,40% | 1,04% | 12.539.844 |
| 08/05/2012 | 36,76 | 36,89 | 36,53 | 36,86 | +0,23% | 0,99% | 9.183.205 |
| 07/05/2012 | 36,75 | 37,03 | 36,74 | 36,77 | -0,77% | 0,80% | 12.129.238 |
| 04/05/2012 | 37,32 | 37,32 | 36,84 | 37,06 | -0,84% | 1,28% | 12.505.155 |
| 03/05/2012 | 37,51 | 37,58 | 37,27 | 37,38 | -0,31% | 0,81% | 11.076.731 |
| 02/05/2012 | 37,52 | 37,62 | 37,30 | 37,49 | -0,20% | 0,86% | 12.082.182 |
| 01/05/2012 | 37,16 | 37,69 | 37,08 | 37,57 | +0,33% | 1,64% | 15.290.320 |
| 30/04/2012 | 36,87 | 37,65 | 36,82 | 37,44 | +2,03% | 2,25% | 20.759.413 |
| 27/04/2012 | 37,02 | 37,16 | 36,58 | 36,70 | -0,03% | 1,55% | 16.259.196 |
| 26/04/2012 | 36,72 | 36,79 | 36,54 | 36,71 | +0,10% | 0,70% | 10.683.731 |
| 25/04/2012 | 36,55 | 36,73 | 36,38 | 36,67 | +0,42% | 0,94% | 13.457.054 |
| 24/04/2012 | 36,58 | 36,67 | 36,42 | 36,52 | +0,00% | 0,68% | 13.084.699 |
| 23/04/2012 | 36,78 | 36,79 | 36,45 | 36,52 | -1,19% | 0,93% | 11.183.522 |
| 20/04/2012 | 36,56 | 37,10 | 36,55 | 36,96 | +0,96% | 1,51% | 15.591.306 |
| 19/04/2012 | 36,78 | 36,85 | 36,41 | 36,60 | -0,10% | 1,19% | 11.256.358 |
| 18/04/2012 | 36,68 | 36,83 | 36,62 | 36,64 | -0,29% | 0,57% | 8.033.339 |
| 17/04/2012 | 36,36 | 36,77 | 36,25 | 36,75 | +1,48% | 1,44% | 11.738.019 |
| 16/04/2012 | 36,15 | 36,32 | 36,15 | 36,21 | +0,45% | 0,48% | 14.607.129 |
| 13/04/2012 | 36,35 | 36,36 | 36,04 | 36,05 | -1,28% | 0,87% | 21.859.289 |
| 12/04/2012 | 36,94 | 36,94 | 36,44 | 36,52 | -0,55% | 1,34% | 13.421.107 |
| 11/04/2012 | 36,84 | 36,93 | 36,64 | 36,72 | +0,08% | 0,78% | 11.224.709 |
| 10/04/2012 | 36,94 | 37,11 | 36,69 | 36,69 | -0,72% | 1,14% | 14.655.337 |
| 09/04/2012 | 36,81 | 37,19 | 36,79 | 36,96 | -0,39% | 1,09% | 12.287.066 |
| 05/04/2012 | 36,98 | 37,13 | 36,82 | 37,10 | -0,05% | 0,83% | 14.547.078 |
| 04/04/2012 | 36,83 | 37,17 | 36,74 | 37,12 | +0,46% | 1,17% | 15.940.918 |
| 03/04/2012 | 36,78 | 36,95 | 36,70 | 36,95 | +0,55% | 0,67% | 11.473.609 |
| 02/04/2012 | 36,55 | 36,79 | 36,46 | 36,75 | +0,29% | 0,91% | 11.990.063 |
| 30/03/2012 | 36,39 | 36,66 | 36,31 | 36,64 | +1,03% | 0,97% | 14.794.302 |
| 29/03/2012 | 36,42 | 36,55 | 36,05 | 36,27 | -0,78% | 1,36% | 18.432.434 |